Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - vaginal fungal infections caused mainly by candida species. vaginal infections caused by trichomonas and microorganisms sensitive to clotrimazole.

Israel - hebraico - Ministry of Health

teva pharmaceutical industries ltd, israel - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - vaginal fungal infections caused mainly by candida species. vaginal infections caused by trichomonas and microorganisms sensitive to clotrimazole.

Israel - hebraico - Ministry of Health

padagis israel pharmaceuticals ltd, israel - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - vaginal fungal infections caused mainly by candida species. vaginal infections caused by trichomonas and microorganisms sensitive to clotrimazole.

Israel - hebraico - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

Israel - hebraico - Ministry of Health

bayer israel ltd - clotrimazole - טבליות וגינליות - clotrimazole 200 mg - clotrimazole - clotrimazole - infections in external female genital organs and vagina caused by clotrimazole-sensitive microorganisms such as fungi (candida albicans) and trichomonas.during treatment of vaginitis caused by trichomonas, canesten v must be combined with an oral trichomonacide (e.g metronidazole).

Israel - hebraico - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 150 mg/ml - medroxyprogesterone - medroxyprogesterone - for contraception where medically indicated and oral administration is inapplicable.

Israel - hebraico - Ministry of Health

comex ltd - oxytetracycline hydrochloride 32.1 mg/ml - spray - oxytetracycline - for the treatment of foot rot and topical infections caused by oxytetracycline-sensitive organisms in sheep.

Israel - hebraico - Ministry of Health

rafa laboratories ltd - minocycline as hydrochloride - קפסולות - minocycline as hydrochloride 50 mg - minocycline - minocycline - treatment of infections caused by tetracycline sensitive organisms, including acne, gonnorrhea and prophylaxis of asymptomatic meningococcal carrier.

Israel - hebraico - Ministry of Health

pfizer pharmaceuticals israel ltd - tigecycline - אבקה מיובשת בהקפאה לאינפוזיה - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosu

Israel - hebraico - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tigecycline - אבקה להכנת תמיסה לאינפוזיה - tigecycline 50 mg/dose - tigecycline - tigecycline - tygacil is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below for patients 18 years of age and older:complicated skin and skin structure infections:complicated skin and skin structure infections caused by escherichia coli, enterococcus faecalis (vancomycin-susceptible isolates ), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus agalactiae, streptococcus anginosus grp. (includes s. anginosus, s. intermedius, and s. constellatus), streptococcus pyogenes, enterobacter cloacae, klebsiella pneumoniae, and bacteroides fragilis .complicated intra-abdominal infections:complicated intra-abdominal infections caused by citrobacter freundii, enterobacter cloacae, escherichia coli, klebsiella oxytoca, klebsiella pneumoniae, enterococcus faecalis (vancomycin-susceptible isolates), staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus anginosus grp. (includes s. anginosu